Principal Investigator: Richard Bergenstal, MD
Study sponsor: Medtronic
Location: International Diabetes Center
Purpose of study: The purpose of this study is to see how well the Minimed 780G insulin pump system works to automatically infuse insulin for control of glucose levels for people with type 2 diabetes who use insulin. This Medtronic MiniMed 780G system consists of an insulin pump, a glucose sensor, a transmitter, and a glucose meter. The system uses continuous glucose readings from the sensor information to tell the insulin pump how much insulin to infuse automatically to help control glucose levels in people who have type 2 diabetes. The MiniMed 780 System and related supplies are provided for use during the study at no cost to qualifying participants.
Involvement in the trial will include:
• Compensation for completed study visits
• Diabetes management and education, support and guidance by diabetes professionals
• Study-related medical care, including regular health checks and lab tests provided at no cost to you
Inclusion Criteria:
The study is accepting individuals ages 18-80 who:
– Have had type 2 diabetes for 2 years or longer
– Take insulin injections or use an insulin pump
– Are willing to use Humalog or Novolog insulin throughout the study
– Meet other study specific criteria
Study Contact:
Caitlin Moening
(952) 993-9605
IDCResearch@parknicollet.com